BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219

Differential expression analysis for sequence count data

Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911

Causal analysis approaches in Ingenuity Pathway Analysis

Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study

Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699

Selective inhibition of BET bromodomains

Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262

Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architecture

McKinsey, T. A., Vondriska, T. M., & Wang, Y. (2018) · F1000Research · doi:10.12688/f1000research.15797.1 · Cited by 25

Integrated bioinformatics and machine learning algorithms reveal the critical cellular senescence-associated genes and immune infiltration in heart failure due to ischemic cardiomyopathy

Ling, G., & Xu, C.-E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1150304 · Cited by 25

Inhibition of BRD4 Reduces Neutrophil Activation and Adhesion to the Vascular Endothelium Following Ischemia Reperfusion Injury

Reid, S., Fine, N. A., Bhosle, V. K., Zhou, J., John, R., Glogauer, M., Robinson, L. A., & Scholey, J. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249620 · Cited by 24

A high-content, in vitro cardiac fibrosis assay for high-throughput, phenotypic identification of compounds with anti-fibrotic activity

Palano, G., Jansson, M., Backmark, A., Martinsson, S., Sabirsh, A., Hultenby, K. R., Åkerblad, P., Granberg, K. L., Jennbacken, K., Müllers, E., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.04.002 · Cited by 25

Shexiang Tongxin Dropping Pill Protects Against Chronic Heart Failure in Mice via Inhibiting the ERK/MAPK and TGF-β Signaling Pathways

Zhang, S., Liu, H., Fang, Q., He, H., Lu, X., Wáng, Y., & Fan, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.796354 · Cited by 23

Protein acetylation in cardiac aging

Francois, A., Canella, A., Marcho, L. M., & Stratton, M. S. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.007 · Cited by 22

The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target

Wołowiec, A., Wołowiec, Ł., Grześk, G., Jaśniak, A., Osiak, J., Husejko, J., & Kozakiewicz, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813723 · Cited by 23

Differential Activation of P-TEFb Complexes in the Development of Cardiomyocyte Hypertrophy following Activation of Distinct G Protein-Coupled Receptors

Martin, R., Sun, Y., MacKinnon, S., Cuccia, L., Pagé, V., Hébert, T. E., & Tanny, J. C. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00048-20 · Cited by 22

Function of BRD4 in the pathogenesis of high glucose‑induced cardiac hypertrophy

Wang, Q., Sun, Y., Li, T., Liu, L., Zhao, Y., Li, L., Zhang, L., & Meng, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9681 · Cited by 23

BRD4 Inhibition Protects Against Myocardial Ischemia/Reperfusion Injury by Suppressing Inflammation and Oxidative Stress Through the PI3K/AKT Signaling Pathway

Wei, H., Xue, Q., Sun, L., & Lv, J. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001138 · Cited by 21

Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts

Brand, C. S., Lighthouse, J. K., & Trembley, M. A. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.023 · Cited by 21

Epigenetic alterations of TGFβ and its main canonical signaling mediators in the context of cardiac fibrosis

Algeciras, L., Palanca, A., Maestro, D., RuizdelRio, J., & Villar, A. V. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.06.003 · Cited by 20

Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity

Wu, C., Cheng, D., Peng, Y., Li, Y., Fu, C., Wang, Y. X., Fu, L., Peng, S., & Ni, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.683506 · Cited by 20

Minimal in vivo requirements for developmentally regulated cardiac long intergenic non-coding RNAs

George, M., Duan, Q., Nagle, A., Kathiriya, I. S., Huang, Y., Rao, K. S., Haldar, S. M., & Bruneau, B. G. (2019) · Development · doi:10.1242/dev.185314 · Cited by 20

Theoretical insight into molecular mechanisms of inhibitor bindings to bromodomain-containing protein 4 using molecular dynamics simulations and calculations of binding free energies

Wang, L., Wang, Y., Sun, H., Zhao, J., & Wang, Q. (2019) · Chemical Physics Letters · doi:10.1016/j.cplett.2019.136785 · Cited by 19

From exosomes to mitochondria and myocardial infarction: Molecular insight and therapeutic challenge

Liu, C. X., Zhang, D., Long, K., Qi, W., Pang, L., Li, J., Cheng, K. K. Y., & Cai, Y. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107468 · Cited by 19

Transcriptional regulation by methyltransferases and their role in the heart: highlighting novel emerging functionality

Szulik, M. W., Davis, K., Bakhtina, A. A., Azarcon, P., Bia, R. D., Horiuchi, E., & Franklin, S. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00382.2020 · Cited by 19

Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats

Xiong, C., Deng, J., Wang, X., Shao, X., Zhou, Q., Zou, H., & Zhuang, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.636154 · Cited by 18

Targeting transcription in heart failure via CDK7/12/13 inhibition

Hsu, A., Duan, Q., Day, D. S., Luo, X., McMahon, S., Huang, Y., Feldman, Z. B., Jiang, Z., Zhang, T., Liang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31541-8 · Cited by 17

Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis

Morgado‐Pascual, J. L., Suárez-Álvarez, B., Marchant, V. A., Basantes, P. E., Tharaux, P., Ortíz, A., López‐Larrea, C., Ruiz‐Ortega, M., & Rayego‐Mateos, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010486 · Cited by 19

Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease

Das, S., Reddy, M. A., & Natarajan, R. D. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000728 · Cited by 18

GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line

Välimäki, M. J., Leigh, R. S., Kinnunen, S. M., March, A. R., de Sande, A. H., Kinnunen, M., Varjosalo, M. T., Heinäniemi, M., Kaynak, B. L., & Ruskoaho, H. J. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02259-z · Cited by 18

How Might Bromodomain and Extra-Terminal (BET) Inhibitors Operate in Cardiovascular Disease?

Schooling, C. M., & Zhao, J. V. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-00315-3 · Cited by 17

Selective inhibitors of bromodomain BD1 and BD2 of BET proteins modulate radiation‐induced profibrotic fibroblast responses

Liu, C., Rioja, I., Bakr, A., Veldwijk, M. R., Sperk, E., Herskind, C., Weichenhan, D., Prinjha, R. K., Plass, C., Schmezer, P., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.33989 · Cited by 17

Bromodomain‐containing protein 4 and its role in cardiovascular diseases

Li, L., Xie, W., Gui, Y., & Zheng, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30225 · Cited by 17

BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury

Sáiz, M. L., Chamizo, L. L., Flórez, A. B., Marciello, M., Díaz-Bulnes, P., Corte-Iglesias, V., Bernet, C. R., Rodrigues-Díez, R. R., Martín-Martín, C., Rodríguez-Santamaría, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116492 · Cited by 16

Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis

Tejedor-Santamaria, L., Morgado‐Pascual, J. L., Márquez‐Expósito, L., Suárez-Álvarez, B., Rodrigues-Díez, R. R., Tejera‐Muñoz, A., Marchant, V. A., Mezzano, S. A., López‐Larrea, C., Solà, A., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15020121 · Cited by 16

N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells

Nord, J. A., Wynia‐Smith, S. L., Gehant, A. L., Jones, R. A., Naatz, A., Rioja, I., Prinjha, R. K., Corbett, J. A., & Smith, B. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.923925 · Cited by 17

BET bromodomain inhibitors regulate keratinocyte plasticity

Schutzius, G., Kolter, C., Bergling, S., Tortelli, F., Fuchs, F., Renner, S., Guagnano, V., Cotesta, S., Rueeger, H., Faller, M., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00716-z · Cited by 17

Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure

Gidlöf, O. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.650124 · Cited by 18

A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates

Fantacuzzi, M., Carradori, S., Giampietro, L., Maccallini, C., Filippis, B. D., Amoroso, R., & Ammazzalorso, A. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117021 · Cited by 15

In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy

Théret, M., Low, M., Rempel, L., Li, F. F., Tung, L. W., Contreras, O., Chang, C.-K., Wu, A., Soliman, H. S., & Rossi, F. M. V. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119482 · Cited by 22

BET Protein-Mediated Transcriptional Regulation in Heart Failure

Ijaz, T., & Burke, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116059 · Cited by 15

Current concepts in the epigenetic regulation of cardiac fibrosis

Hassanabad, A. F., Zarzycki, A. N., Patel, V. B., & Fedak, P. W. M. (2024) · Cardiovascular Pathology · doi:10.1016/j.carpath.2024.107673 · Cited by 16

Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure PathogenesisPreprint

Alexanian, M., Padmanabhan, A., Nishino, T., Travers, J. G., Ye, L., Lee, C. Y., Sadagopan, N., Huang, Y., Pelonero, A., Auclair, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.06.522937 · Cited by 14

(+)-JQ-1 alleviates cardiac injury in myocardial infarction by inhibiting ferroptosis through the NAMPT/SIRT1 pathway

Yang, M., Wang, T., Shao, J., Ran, X., Xiao, R., Zhao, R., Wu, C., Ji, M., Tian, W., Sun, H., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07880-x · Cited by 15

BRD4 inhibition rewires cardiac macrophages toward a protective phenotype marked by low MHC class II expression

Schuetze, K. B., Stratton, M. S., Bagchi, R. A., Hobby, A. R. H., Felisbino, M. B., Rubino, M., Toni, L. S., Reges, C. R., Cavasin, M. A., McMahan, R. H., et al. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00438.2024 · Cited by 14

Molecular basis of GDF15 induction and suppression by drugs in cardiomyocytes and cancer cells toward precision medicine

Winter, L.-M., Reinhardt, D., Schatter, A., Tissen, V., Wiora, H., Gerlach, D., Tontsch-Grunt, U., Colbatzky, F., Stierstorfer, B., & Yun, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-38450-w · Cited by 15

Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis

Fu, R., Zu, S.-J., Liu, Y.-J., Li, J.-C., Dang, W.-Z., Liao, L.-P., Liu, L.-P., Chen, P.-Y., Huang, H.-M., Wu, K.-H., et al. (2022) · Bioengineered · doi:10.1080/21655979.2022.2066756 · Cited by 12

Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulators

Tsujikawa, L. M., Kharenko, O. A., Stotz, S. C., Rakai, B. D., Sarsons, C. D., Gilham, D., Wasiak, S., Fu, L., Sweeney, M., Johansson, J. O., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113230 · Cited by 13

Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues

Reyat, J. S., Maio, A. D., Grygielska, B., Pike, J. A., Kemble, S., Rodriguez-Romero, A., Karali, C. S., Croft, A. P., Psaila, B., Simões, F. C., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1156759 · Cited by 12

Molecular signature of RV cardiac remodeling associated with Polymerase Gamma mutation

Gorr, M. W., Francois, A., Marcho, L. M., Saldaña, T., McGrail, E., Sun, N., & Stratton, M. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120469 · Cited by 13

Histone Deacetylase 6 Inhibitor JS28 Prevents Pathological Gene Expression in Cardiac Myocytes

Ngo, V., Fleischmann, B. K., Jung, M., Hein, L., & Lother, A. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025857 · Cited by 12

The BRD4 inhibitor JQ1 protects against chronic obstructive pulmonary disease in mice by suppressing NF-κB activation.

Liu, Y., Huang, Z., Li, M., Li, Z., & Chen, K. (2021) · PubMed · doi:10.14670/hh-18-283 · Cited by 12

Epigenetic remodeling in heart failure with preserved ejection fraction

Ambrosini, S., Gorica, E., Mohammed, S. A., Costantino, S., Ruschitzka, F., & Paneni, F. (2022) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000961 · Cited by 12

BET inhibitor attenuates heart failure

Cully, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.125 · Cited by 12

BRD4 as a therapeutic target for atrial fibrosis and atrial fibrillation

Song, S., Yuan, J., Fang, G., Li, Y., Ding, S., Wang, Y., & Wang, Q. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176714 · Cited by 12

A Role for Polo-Like Kinase 4 in Vascular Fibroblast Cell-Type Transition

Li, J., Urabe, G., Huang, Y., Zhang, M., Wang, B., Marcho, L. M., Shen, H., Kent, K. C., & Guo, L. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.12.015 · Cited by 11

BRD4 inhibition slows HF progression

Ummarino, D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.86 · Cited by 11

Heart-on-a-chip and vasculature-on-a-chip platforms as models of cardiovascular disease

Khosravi, R., & Radisic, M. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01255-1 · Cited by 12

The roles and mechanisms of epigenetic regulation in pathological myocardial remodeling

Zhao, K., Mao, Y., Li, Y., Yang, C., Wang, K., & Zhang, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.952949 · Cited by 10

Spinal-Specific Super Enhancer in Neuropathic Pain

Tao, Y., Wang, Q., Li, X., Liu, Y., Sun, R.-H., Xu, H., Zhang, M., Siyuan, L., Li, Y., Wang, H., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1006-23.2023 · Cited by 10

Epigenetics of cardiomyopathies: the next frontier

Hajdarpašić, A., Tukker, M., Rijdt, W. P. T., Mohamedhoesein, S., Meijers, W. C., & Çalişkan, K. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10460-4 · Cited by 11

Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy

Russell‐Hallinan, A., Karuna, N., Lezoualc’h, F., Matullo, G., Baker, H. E., Bernard, M., Devaux, Y., Badimón, L., Vilahur, G., Rieusset, J., et al. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70081 · Cited by 9

Environmental factors influence somatic cell reprogramming to cardiomyocyte-like cells

Handel, B. V., Wang, L., & Ardehali, R. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.028 · Cited by 10

Transcriptional regulation of cardiac fibroblast phenotypic plasticity

Villar, K. N. B., Liu, X., & Small, E. M. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100556 · Cited by 11

TAF1 bromodomain inhibition as a candidate epigenetic driver of congenital heart disease

Leigh, R. S., Välimäki, M. J., Kaynak, B. L., & Ruskoaho, H. J. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166689 · Cited by 10

Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure

Minerath, R. A., Hall, D. D., & Grueter, C. E. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09792-3 · Cited by 12

Epigenetic remodeling in heart failure with preserved ejection fraction

Ambrosini, S., Gorica, E., Mohammed, S. A., Costantino, S., Ruschitzka, F. T., & Paneni, F. (2022) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-229357 · Cited by 10

Rbfox1 controls alternative splicing of focal adhesion genes in cardiac muscle cells

Zorn, P., Sánchez, J. C., Alakhras, T., Schreier, B., Gekle, M., Hüttelmaier, S., & Köhn, M. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae003 · Cited by 10

State of change: epigenetic and mitochondrial regulation of cardiac fibroblast activation

Garvin, A. M., & Hale, T. M. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100557 · Cited by 9

The epigenetic regulator BRD4 is required for myofibroblast differentiation of knee fibroblasts

Dudakovic, A., Bayram, B., Bettencourt, J. W., Limberg, A. K., Galvan, M. L., Carrasco, M. E., Stans, B., Thaler, R., Morrey, M. E., Sánchez‐Sotelo, J., et al. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30368 · Cited by 9

Cardiac-specific overexpression of PRMT5 exacerbates pressure overload-induced hypertrophy and heart failure

Katanasaka, Y., Sunagawa, Y., Sakurai, R., Tojima, M., Naruta, R., Hojo, Y., Kawase, Y., Hamabe‐Horiike, T., Mori, K., Hasegawa, K., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01162-6 · Cited by 9

Potential Applications of Induced Pluripotent Stem Cells for Cardiovascular Diseases

Wang, X., Han, Z., Yu, Y., Xu, Z., Cai, B., & Yuan, Y. (2018) · Current Drug Targets · doi:10.2174/1389450120666181211164147 · Cited by 9

Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity

Estoppey, D., Schutzius, G., Kolter, C., Salathe, A., Wunderlin, T., Meyer, A., Nigsch, F., Bouwmeester, T., Hoepfner, D., & Kirkland, S. C. (2021) · iScience · doi:10.1016/j.isci.2021.103323 · Cited by 9

The JMJD family of histone demethylase and their intimate links to cardiovascular disease

Xie, J., Lin, H., Zuo, A., Shao, J., Sun, W., Wang, S., Jianda, S., Wang, Y., Luo, Y., Sun, J. M., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111046 · Cited by 8

BRD4 as the key lactylation related gene in heart failure identified through bioinformatics analysis

Li, K., Han, L., Wang, X., Zheng, Z., Sha, M., Ye, J., & Zhu, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-91506-x · Cited by 8

Gβγ subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblasts

Khan, S. M., Martin, R., Bayne, A. N., Pétrin, D., Bourque, K., Jones-Tabah, J., Bouazza, C. A., Blaney, J., Lau, J., Martins-Cannavino, K., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103064 · Cited by 8

Drugging transcription in heart failure

Padmanabhan, A., & Haldar, S. M. (2019) · The Journal of Physiology · doi:10.1113/jp276745 · Cited by 8

Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic Studies

Sharma, S. M., Pettus, J., Gottschalk, M. E., Abe, B. T., Gottlieb, P. A., & Teyton, L. (2019) · Diabetes · doi:10.2337/dbi18-0064 · Cited by 9

Intramolecular Cyclization of Brominated Oxime Ether Promoted with Ytterbium(0) to the Synthesis of Cyclic Imines

Wang, Y., Huang, F., & Zhang, S. (2020) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202000678 · Cited by 8

The Cardiac Myofibroblast

Alexanian, M., & Haldar, S. M. (2018) · Circulation Research · doi:10.1161/circresaha.118.314185 · Cited by 8

Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease

Doskey, L. C., Scholtz, C. R., Vail, N. R., Khanal, S., Lee, A. L., Kandanur, S. G. S., Hoell, Z. J., Huehls, A. M., Issa, M. R., Kostallari, E., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02555 · Cited by 9

Metabo-epigenetic circuits of heart failure: chromatin-modifying enzymes as determinants of metabolic plasticity

Pepin, M. E., Gong, X., Schulze, A., & Backs, J. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00343-y · Cited by 8

Quantifying the Selectivity of Protein–Protein and Small Molecule Interactions with Fluorinated Tandem Bromodomain Reader Proteins

Kalra, P., McGraw, L., Kimbrough, J. R., Pandey, A. K., Solberg, J. C., Cui, H., Divakaran, A., John, K., Hawkinson, J. E., & Pomerantz, W. C. K. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00720 · Cited by 7

Recent Developments in Targeting Bromodomain and Extra Terminal Domain Proteins for Cancer Therapeutics

Cai, M., Dong, J., Li, H., & Qin, J. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220211091806 · Cited by 7

Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis

Banham, G. D., Lee, C. Y. C., Ferdinand, J. R., Matthews, R. J., Jing, C., Smithers, N. N., Prinjha, R. K., & Clatworthy, M. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.885101 · Cited by 8

Pressure Overload Activates DNA-Damage Response in Cardiac Stromal Cells: A Novel Mechanism Behind Heart Failure With Preserved Ejection Fraction?

Stadiotti, I., Santoro, R., Scopece, A., Pirola, S., Guarino, A., Polvani, G., Maione, A. S., Ascione, F., Li, Q., Delia, D., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.878268 · Cited by 7

JQ1 is a potential therapeutic option for COPD patients with agrin overexpression

Xiao, Z., Shu, J., Zhou, F., & Han, Y. K. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00500.2017 · Cited by 7

cellHarmony: Cell-level matching and holistic comparison of single-cell transcriptomesPreprint

DePasquale, E. A., Dexheimer, P., Schnell, D., Ferchen, K., Hay, S., Valiente-Alandí, Í., Blaxall, B. C., Grimes, H. L., & Salomonis, N. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/412080 · Cited by 8

Histone Modifications in Cardiovascular Disease: Mechanisms and Therapeutic Opportunities

Zheng, Y., Gao, Y., Guo, M., Wang, L., Zheng, X., Liao, Y., Li, Y., Zhu, J.-P., & Wei, J. (2026) · MedComm · doi:10.1002/mco2.70765 · Cited by 7

Characterizing a long-term chronic heart failure model by transcriptomic alterations and monitoring of cardiac remodeling

Zhu, Y., Wang, Q., Lin, H., Chen, K., Zheng, C., Chen, L., Ma, S., Liao, W., Bin, J., & Liao, Y. (2021) · Aging · doi:10.18632/aging.202879 · Cited by 6

Transcriptional plasticity of fibroblasts in heart disease

Micheletti, R., & Alexanian, M. (2022) · Biochemical Society Transactions · doi:10.1042/bst20210864 · Cited by 7

Identification of transcription factors MYC and C/EBPβ mediated regulatory networks in heart failure based on gene expression omnibus datasets

Wang, H., Wang, X., Xu, L., & Cao, H. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01527-9 · Cited by 7

Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure

Venanzio, L. D., Atzemian, N., Weber, B. Y., Gorica, E., Kleeberger, J., Mohammed, S. A., Costantino, S., Dzemali, O., Ruschitzka, F. T., & Paneni, F. (2025) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.08.001 · Cited by 5

Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors

Roth, R., Häckh, M., Schnick, T., Rommel, C., Koentges, C., Bugger, H., Domisch, C., Bristow, M. R., Ambardekar, A. V., McKinsey, T. A., et al. (2025) · Epigenetics · doi:10.1080/15592294.2025.2506625 · Cited by 5

Roles of Bromodomain Extra Terminal Proteins in Metabolic Signaling and Diseases

Wu, D., & Duan, Q. (2022) · Pharmaceuticals · doi:10.3390/ph15081032 · Cited by 5

Co-administration of JQ1, a bromodomain-containing protein 4 inhibitor, enhances the antitumor effect of combretastatin A4, a microtubule inhibitor, while attenuating its cardiotoxicity

Orihara, H., Ma, M., Nagashima, Y., Tochinai, R., Sekizawa, S., Kato, D., Shinada, M., Aoki, S., Fujita, N., Nakagawa, T., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114353 · Cited by 5

A review on decoding the roles of YAP/TAZ signaling pathway in cardiovascular diseases: Bridging molecular mechanisms to therapeutic insights

Zhang, Y., Ren, Y., Li, X., Li, M., Fu, M., Zhou, W., Yu, Y., & Xiong, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132473 · Cited by 5

Targeting fibrosis in the Duchenne Muscular Dystrophy mice model: an uphill battlePreprint

Théret, M., Low, M., Rempel, L., Li, F. F., Tung, L. W., Contreras, O., Chang, C.-K., Wu, A., Soliman, H., & Rossi, F. M. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.20.427485 · Cited by 5

Discovery and anti-tumor activity of 4-(benzylamino)-6-(3,5-dimethylisoxazol-4-yl)quinolin-2(1H)-one (CG13250), a potent, selective and orally bioavailable BET bromodomain inhibitor

Chauhan, J., Yoshioka, M., Pogash, S., Strovel, J. W., & Fletcher, S. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129220 · Cited by 4

Fibroblasts—The emerging therapeutic target of the cardiovascular system?

Asselberghs, S., Halder, M., Kramann, R., & Sluimer, J. C. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100072 · Cited by 4

Advances in BRD proteins in cardiovascular pathophysiology and therapy: A review

Jiang, Y., Jiang, J., Feng, S., & Zhu, R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148798 · Cited by 4

Current opinion in cardiology, epigenetics of heart failure

El‐Osta, A. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001279 · Cited by 4

BET bromodomain inhibitors attenuate transcription of a subset of IL-1-induced NF-κB targets that promote inflammation in β-cells

Nord, J. A., Makowski, S. J., Sidlowski, P. F. W., Bursch, K. L., Corbett, J. A., & Smith, B. C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110358 · Cited by 4

The Current Therapeutic Role of Chromatin Remodeling for the Prognosis and Treatment of Heart Failure

Kraus, L., & Beavens, B. (2023) · Biomedicines · doi:10.3390/biomedicines11020579 · Cited by 4

The effect of JQ1 systemic administration on oxidative stress and apoptotic markers in renal ischemic reperfusion injury in a rat model

Younis, S. S., Ghafil, F. A., Majeed, S. A., & Hadi, N. R. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2022-0287 · Cited by 4

The epigenetic regulation of crosstalk between cardiac fibroblasts and other cardiac cell types during stress

Kraus, L., Fredericks, S., & Scheeler, K. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1539826 · Cited by 3

Long-lasting metabolic impairment in the failing heart: epigenetic memories at play

Costantino, S., & Paneni, F. (2025) · Epigenetics · doi:10.1080/15592294.2025.2515430 · Cited by 3

Recharging the Powerhouse: Mitochondrial Dysfunction and Therapy in Cardiorenal Syndrome Type 4

Long, E., & Heihre, J. M. (2025) · Current Heart Failure Reports · doi:10.1007/s11897-025-00713-0 · Cited by 4

BRD4 inhibition slows HF progression

Ummarino, D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.86 · Cited by 11

BET inhibitor attenuates heart failure

Cully, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.125 · Cited by 12

BET Protein-Mediated Transcriptional Regulation in Heart Failure

Ijaz, T., & Burke, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116059 · Cited by 15

BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy

Antolic, A., Wakimoto, H., Jiao, Z., Gorham, J. M., DePalma, S. R., Lemieux, M. E., Conner, D. A., Lee, D. Y., Qi, J., Seidman, J. G., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138687 · Cited by 41

From Chromatin Readers to Heart Failure: BET Protein Family Members in Cardiac Remodeling

Lbik, D. (2019) · doi:10.53846/goediss-7453 · Cited by 1